Cancer Institute A national cancer institute
designated cancer center

Gestational Trophoblastic Disease Expertise

Gestational trophoblastic disease (GTD) is a set of diseases that arise from cells related to pregnancy that become cancerous. GTD occurs following fertilization when placenta forms in the absence of a fetus, or with a partial and abnormal fetus. GTD can follow a normal full-term pregnancy, an ectopic pregnancy, a miscarriage or an abortion.

Detection, treatment and follow-up care are critical if you have GTD. Treatment almost always results in a cure, but the disease can reoccur and needs to be addressed promptly.

Our Gynecologic Cancer physicians, located in the new Stanford’s Women’s Cancer Center have extensive experience in the treatment of GTD, and can manage your follow-up care which will initially include weekly testing, followed by monthly, and then bi-monthly testing for at least a year.

Our skilled staff also provides compassionate care and will provide support to help you cope with this emotionally difficult condition.

Stanford Medicine Resources:

Footer Links: